SGK1-IN-8 (compound 55) is a SGK1 and GSK3β inhibitor, with an IC 50 of 0.11 μM against human SGK1 and an IC 50 of 3.39 μM against human GSK3β . SGK1-IN-8 inhibits the catalytic activities of SGK1 and GSK3β , and reduces the phosphorylation level of TAU protein at the Ser214 site. SGK1-IN-8 is available for the research of Alzheimer's disease.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > SGK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.